Laboratory Of Stock Alpha and Beta Analysis
| LH Stock | USD 250.20 1.46 0.58% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Laboratory of. It also helps investors analyze the systematic and unsystematic risks associated with investing in Laboratory over a specified time horizon. Remember, high Laboratory's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Laboratory's market risk premium analysis include:
Beta 0.49 | Alpha (0.22) | Risk 1.49 | Sharpe Ratio (0.11) | Expected Return (0.16) |
Laboratory Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Laboratory | Build AI portfolio with Laboratory Stock |
Laboratory Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Laboratory market risk premium is the additional return an investor will receive from holding Laboratory long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Laboratory. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Laboratory's performance over market.| α | -0.22 | β | 0.49 |
Laboratory expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Laboratory's Buy-and-hold return. Our buy-and-hold chart shows how Laboratory performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Laboratory Market Price Analysis
Market price analysis indicators help investors to evaluate how Laboratory stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Laboratory shares will generate the highest return on investment. By understating and applying Laboratory stock market price indicators, traders can identify Laboratory position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Simple Moving Average | ||
| Parabolic SAR | ||
| Stalled Pattern | ||
| Separating Lines |
Laboratory Return and Market Media
The median price of Laboratory for the period between Tue, Oct 7, 2025 and Mon, Jan 5, 2026 is 264.6 with a coefficient of variation of 4.3. The daily time series for the period is distributed with a sample standard deviation of 11.4, arithmetic mean of 265.25, and mean deviation of 9.55. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Dynamic Technology Lab Private Ltd Sells 5,910 Shares of Labcorp Holdings Inc. LH | 11/21/2025 |
2 | Skandinaviska Enskilda Banken AB publ Has 7.12 Million Position in Labcorp Holdings Inc. LH | 12/01/2025 |
3 | Testing Diagnostics Services Stocks Q3 Recap Benchmarking NeoGenomics | 12/05/2025 |
| Laboratory dividend paid on 11th of December 2025 | 12/11/2025 |
5 | Rosalind Franklin University Welcomes Tolmars New Northern Illinois Laboratory at Its Innovation and Research Park | 12/16/2025 |
6 | KILL MIT Lincoln Laboratory Enhances Experiment Execution by Extending Eyelits MES Deployment Through Its Advanced SWR Module | 12/18/2025 |
7 | InSilicoTrials With The Jackson Laboratory Lead CARDIOVERSE, a 30M Initiative Funded by ARPA-H to Redefine Cardiac Drug Safety with Virtual Heart Models | 12/22/2025 |
8 | Foresee Pharmaceuticals announces the Casppian Phase 3 Study Meets Primary Efficacy Endpoint, Demonstrating Robust LH Suppression with 6-Month Dosing Interval o... | 12/24/2025 |
9 | Rocket Lab Takes Off On Contract Win, Triggers This Rare Bullish Signal - Investors Business Daily | 12/26/2025 |
10 | Rocket Lab stock tumbles after record run heres what investors are watching - ts2.tech | 12/29/2025 |
11 | Rocket Lab The Market Is Saying This Is An Outlier Amongst Outliers - Seeking Alpha | 01/02/2026 |
About Laboratory Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Laboratory or other stocks. Alpha measures the amount that position in Laboratory has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0128 | 0.0126 | 0.0145 | 0.0138 | Price To Sales Ratio | 1.63 | 1.48 | 1.7 | 1.6 |
Laboratory Upcoming Company Events
As portrayed in its financial statements, the presentation of Laboratory's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Laboratory's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Laboratory's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Laboratory. Please utilize our Beneish M Score to check the likelihood of Laboratory's management manipulating its earnings.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Laboratory
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Laboratory Backtesting, Laboratory Valuation, Laboratory Correlation, Laboratory Hype Analysis, Laboratory Volatility, Laboratory History and analyze Laboratory Performance. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Laboratory technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.